The Valley Desk

NCT00834496 · Observational study

Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation

Overall registry status Withdrawn

Conditions Hepatic Fibrosis on Biopsy, Neurotoxicity, Post Transplant Diabetes, Renal Toxicity, Side Effects of Calcineurin Inhibitors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov